174 related articles for article (PubMed ID: 16707884)
1. Primary focal hyperhidrosis: disease characteristics and functional impairment.
Hamm H; Naumann MK; Kowalski JW; Kütt S; Kozma C; Teale C
Dermatology; 2006; 212(4):343-53. PubMed ID: 16707884
[TBL] [Abstract][Full Text] [Related]
2. Prospective open-label study of botulinum toxin type A in patients with axillary hyperhidrosis: effects on functional impairment and quality of life.
Solish N; Benohanian A; Kowalski JW;
Dermatol Surg; 2005 Apr; 31(4):405-13. PubMed ID: 15871315
[TBL] [Abstract][Full Text] [Related]
3. Treatment of axillary hyperhidrosis by chemodenervation of sweat glands using botulinum toxin type A.
Glaser DA
J Drugs Dermatol; 2004; 3(6):627-31. PubMed ID: 15624745
[TBL] [Abstract][Full Text] [Related]
4. Treatment of focal idiopathic hyperhidrosis with Botulinum Toxin Type A: clinical predictive factors of relapse-free survival.
Campanati A; Sandroni L; Gesuita R; Giuliano A; Giuliodori K; Marconi B; Ganzetti G; Offidani A
J Eur Acad Dermatol Venereol; 2011 Aug; 25(8):917-21. PubMed ID: 21054569
[TBL] [Abstract][Full Text] [Related]
5. US prevalence of hyperhidrosis and impact on individuals with axillary hyperhidrosis: results from a national survey.
Strutton DR; Kowalski JW; Glaser DA; Stang PE
J Am Acad Dermatol; 2004 Aug; 51(2):241-8. PubMed ID: 15280843
[TBL] [Abstract][Full Text] [Related]
6. Treatment of focal axillary hyperhidrosis using a long-pulsed Nd:YAG 1064 nm laser at hair reduction settings.
Letada PR; Landers JT; Uebelhoer NS; Shumaker PR
J Drugs Dermatol; 2012 Jan; 11(1):59-63. PubMed ID: 22206078
[TBL] [Abstract][Full Text] [Related]
7. Assessment of quality of life in patients with primary axillary hyperhidrosis before and after suction-curettage.
Bechara FG; Gambichler T; Bader A; Sand M; Altmeyer P; Hoffmann K
J Am Acad Dermatol; 2007 Aug; 57(2):207-12. PubMed ID: 17368632
[TBL] [Abstract][Full Text] [Related]
8. Botulinum toxin type A in the treatment of primary axillary hyperhidrosis: a 52-week multicenter double-blind, randomized, placebo-controlled study of efficacy and safety.
Lowe NJ; Glaser DA; Eadie N; Daggett S; Kowalski JW; Lai PY;
J Am Acad Dermatol; 2007 Apr; 56(4):604-11. PubMed ID: 17306417
[TBL] [Abstract][Full Text] [Related]
9. Daily pattern of sweating and response to stress and exercise in patients with palmar hyperhidrosis.
Krogstad AL; Mork C; Piechnik SK
Br J Dermatol; 2006 Jun; 154(6):1118-22. PubMed ID: 16704643
[TBL] [Abstract][Full Text] [Related]
10. Dilution of botulinum toxin A in lidocaine vs. in normal saline for the treatment of primary axillary hyperhidrosis: a double-blind, randomized, comparative preliminary study.
Güleç AT
J Eur Acad Dermatol Venereol; 2012 Mar; 26(3):314-8. PubMed ID: 21492253
[TBL] [Abstract][Full Text] [Related]
11. Botulinum toxin A for axillary hyperhidrosis (excessive sweating).
Heckmann M; Ceballos-Baumann AO; Plewig G;
N Engl J Med; 2001 Feb; 344(7):488-93. PubMed ID: 11172190
[TBL] [Abstract][Full Text] [Related]
12. [Focal hyperhidrosis: disease characteristics and treatments].
Campanelli A; Salomon D
Rev Med Suisse; 2009 Apr; 5(200):870-5. PubMed ID: 19438086
[TBL] [Abstract][Full Text] [Related]
13. Health-related quality of life after thoracoscopic sympathectomy for palmar hyperhidrosis.
Kumagai K; Kawase H; Kawanishi M
Ann Thorac Surg; 2005 Aug; 80(2):461-6. PubMed ID: 16039186
[TBL] [Abstract][Full Text] [Related]
14. Tumescent suction curettage versus minimal skin resection with subcutaneous curettage of sweat glands in axillary hyperhidrosis.
Wollina U; Köstler E; Schönlebe J; Haroske G
Dermatol Surg; 2008 May; 34(5):709-16. PubMed ID: 18318727
[TBL] [Abstract][Full Text] [Related]
15. Selective sweat gland removal with minimal skin excision in the treatment of axillary hyperhidrosis: a retrospective clinical and histological review of 15 patients.
Lawrence CM; Lonsdale Eccles AA
Br J Dermatol; 2006 Jul; 155(1):115-8. PubMed ID: 16792762
[TBL] [Abstract][Full Text] [Related]
16. Diode laser hair removal does not interfere with botulinum toxin A treatment against axillary hyperhidrosis.
Paul A; Kranz G; Schindl A; Kranz GS; Auff E; Sycha T
Lasers Surg Med; 2010 Mar; 42(3):211-4. PubMed ID: 20333738
[TBL] [Abstract][Full Text] [Related]
17. Uniportal endoscopic thoracic sympathectomy for treatment of palmar and axillary hyperhidrosis: analysis of 2000 cases.
Lin TS; Kuo SJ; Chou MC
Neurosurgery; 2002 Nov; 51(5 Suppl):S84-7. PubMed ID: 12234434
[TBL] [Abstract][Full Text] [Related]
18. Evaluating the patient presenting with hyperhidrosis.
Solish N; Wang R; Murray CA
Thorac Surg Clin; 2008 May; 18(2):133-140. PubMed ID: 18557587
[TBL] [Abstract][Full Text] [Related]
19. Botulinum toxin type a is a safe and effective treatment for axillary hyperhidrosis over 16 months: a prospective study.
Naumann M; Lowe NJ; Kumar CR; Hamm H;
Arch Dermatol; 2003 Jun; 139(6):731-6. PubMed ID: 12810503
[TBL] [Abstract][Full Text] [Related]
20. Superiority of thoracoscopic sympathectomy over medical management for the palmoplantar subset of severe hyperhidrosis.
Baumgartner FJ; Bertin S; Konecny J
Ann Vasc Surg; 2009; 23(1):1-7. PubMed ID: 18619780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
